Table of Commonly Used IV Solutions

Please scroll down for the complete table


If possible do not LR or D5LR type of dextrose.
Read these to know more about the side effects of D5LR
D5LR (Lactated Ringer's Solution)
What are Lactated Ringers (Risks and Contraindications)
DLR or D5LR increases death in cardiac arrest cases
DLR and D5LR exacerabates renal problems



Please scroll down for the complete table





Please scroll down for the complete table





Table of Commonly Used IV Solutions

Name of
Solution
Type of
Solution
Ingredients in
1-Liter
Uses
Complications
0.45% Sodium
Chloride

Shorthand Notation:
½NS
Hypotonic pH 5.6
77 mEq Sodium
77 mEq Chloride
hypotonic hydration; replace sodium and chloride; hyperosmolar diabetes
if too much is mixed with blood cells during
transfusions, the cells will pull water into them and rupture
0.9% Sodium
Chloride

Shorthand Notation: NS
Isotonic pH 5.7
154 mEq Sodium
154 mEq Chloride
isotonic hydration; replace sodium and chloride; alkalosis; blood transfusions
(will not hemolyze blood cells)
None known
3% Sodium Chloride
Hypertonic pH 5.0
513 mEq Sodium
513 mEq Chloride

symptomatic hyponatremia due to excessive sweating, vomiting, renal impairment, and excessive water intake


rapid or continuous infusion can result in hypernatremia or hyperchloremia
5% Sodium Chloride
Hypertonic pH 5.8
855 mEq Sodium
855 mEq Chloride
5% Dextrose in
Water

Shorthand Notation: D5W
Isotonic pH 5.0
5 grams dextrose
(170 calories/liter)
isotonic hydration; provides some calories






water intoxication and dilution of body's electrolytes with long, continuous infusions
10% Dextrose in
Water

Shorthand Notation: D10W
Hypertonic pH 4.3
10 grams dextrose
(340 calories/liter)
may be infused peripherally; hypertonic hydration; provides some calories
5% Dextrose in 1/4
Strength (or 0.25%) Saline

Shorthand Notation: D5¼NS
Hypertonic pH 4.4
5 grams Dextrose
34 mEq Sodium
34 mEq Chloride
fluid replacement;
replacement of sodium, chloride and some calories
vein irritation because of acidic pH, causes agglomeration (clustering) if used with blood transfusions; hyperglycemia with rapid infusion leading to osmotic



5% Dextrose in 0.45
Sodium Chloride

Shorthand Notation: D5½NS
Hypertonic pH 4.4
5 grams Dextrose
77 mEq Sodium
77 mEq Chloride
hypertonic fluid replacement;
replace sodium, chloride, and some calories
diuresis
5% Dextrose in
Normal Saline

Shorthand Notation: D5NS
Hypertonic pH 4.4
5 grams Dextrose
154 mEq Sodium
154 mEq Chloride
hypertonic fluid replacement; replace sodium, chloride and some calories
Ringer’s Injection,
U.S.P.
Isotonic pH 5.8
147 mEq Sodium
4 mEq Potassium
4 mEq Calcium
155 mEq Chloride
electrolyte replacement; hydration; often used to replace extracellular fluid losses
rapid administration leads to excessive introduction of electrolytes and leads to fluid overload and congestive
conditions; provides no
calories and is not an adequate maintenance solution if abnormal fluid losses are present
Lactated Ringer’s

Shorthand Notation: LR
Isotonic pH 6.6
130 mEq Sodium
4 mEq Potassium
3 mEq Calcium
109 mEq Chloride
28 mEq Sodium Lactate (provides 9 calories/liter)
isotonic hydration; replace electrolytes and extra- cellular fluid losses; mild to
moderate acidosis (the lactate
is metabolized into
bicarbonate which counteracts the acidosis)







not enough electrolytes for maintenance; patients with hepatic disease have trouble metabolizing the lactate; do not use if lactic acidosis is present
5% Dextrose in Lactated Ringer’s Injection

Shorthand Notation: D5LR
Hypertonic pH 4.9
5 grams Dextrose
(170 calories/liter)
130 mEq Sodium
4 mEq Potassium
3 mEq Calcium
109 mEq Chloride
28 mEq Sodium Lactate (provides 9 calories/liter)
hypertonic hydration;
provides some calories;
replace electrolytes and extra- cellular fluid losses; mild to moderate acidosis (the lactate is metabolized into
bicarbonate which counteracts the acidosis), the dextrose minimizes glycogen depletion




1986 Sep;100(3):505-11.

Dextrose containing intravenous fluid impairs outcome and increases death after eight minutes of cardiac arrest and resuscitation in dogs.

Abstract

Use of dextrose in intravenous resuscitation fluids is common practice; however, this study indicates that 5% dextrose solutions, even if administered in physiologic quantities, greatly worsens the outcome of survivable cardiac arrest. Twelve adult male mongrel dogs were premedicated with morphine, anesthetized with halothane, instrumented, intubated, and ventilated. Each dog was first given 500 ml of either lactated Ringer's (LR) (n = 6) or 5% dextrose in LR (D5LR) (n = 6). Halothane was stopped and fibrillation was induced (60 Hz). Blood glucose just before cardiac arrest was 129 mg/dl in the LR dogs and was increased to 335 mg/dl in the D5LR dogs. After eight minutes of arrest, resuscitation, including internal cardiac massage and standard advanced cardiac life support drug protocols (modified for dogs), was begun. When stable cardiac rhythm was obtained, the chest was closed, and LR or D5LR continued until a total of 1L was given. A neurologic score (0 = normal to 100 = dead) was assigned at 1, 2, 6, and 24 hours. The LR group did not differ statistically from the D5LR group in operative time, number of defibrillatory shocks, time to spontaneous ventilation, time to extubation, or drugs required. Resuscitation was successful in all six LR and five of six D5LR group; however, by 2 hours after resuscitation and thereafter, D5LR group had a significantly greater neurologic deficit (p less than 0.05) than did the LR group. By 9 hours, four of six D5LR dogs displayed convulsive activity and died. At 24 hours the D5LR group had a greater (p less than 0.008) neurologic deficit (82 +/- 11) than did the LR group (21 +/- 7), which walked and ate. We conclude that the addition of 5% dextrose to standard intravenous fluids greatly increases the morbidity and mortality associated with cardiac resuscitation.
PMID:
3738770
[PubMed - indexed for MEDLINE]

Comments

Popular posts from this blog

FAQ: ADSX Solution (Anti-Dengue Solution)

Dengue: Read this first

Why the WHO's Dengue Strategy Is Wrong